{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bladder&page=11", "query": { "condition": "Bladder", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 1852, "total_pages": 186, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bladder&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bladder&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T14:23:22.549Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03636256", "title": "Evaluation of NanoDoce® in Participants With Urothelial Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Bladder Cancer", "Urothelial Carcinoma", "Urinary Bladder Neoplasm", "Urinary Bladder Cancer", "Urogenital Neoplasms", "Urologic Neoplasms", "Urologic Cancer", "Malignant Tumor of the Urinary Bladder", "Cancer of the Bladder" ], "interventions": [ { "name": "NanoDoce (direct injection)", "type": "DRUG" }, { "name": "NanoDoce (intravesical instillation) - Visit 2 Instillation", "type": "DRUG" }, { "name": "Institutional Standard of Care", "type": "OTHER" }, { "name": "NanoDoce (intravesical instillation) - Induction and Maintenance Instillations", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "NanOlogy, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2019-04-02", "completion_date": "2021-11-02", "has_results": true, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Baltimore, Maryland • New York, New York + 2 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" }, { "city": "Myrtle Beach", "state": "South Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03636256" }, { "nct_id": "NCT03653702", "title": "Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Vesico-Ureteral Reflux" ], "interventions": [ { "name": "Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "35 Years", "sex": "ALL", "summary": "6 Months to 35 Years" }, "enrollment_count": 70, "start_date": "2027-07-01", "completion_date": "2029-07", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03653702" }, { "nct_id": "NCT04873037", "title": "BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Overactive Bladder Syndrome", "Overactive Bladder", "Urinary Frequency", "Urinary Urgency" ], "interventions": [ { "name": "BTL Emsella Chair", "type": "DEVICE" }, { "name": "Sham BTL Emsella Chair", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Corewell Health East", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 166, "start_date": "2021-11-22", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 1, "location_summary": "Royal Oak, Michigan", "locations": [ { "city": "Royal Oak", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04873037" }, { "nct_id": "NCT03980041", "title": "Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bladder Cancer", "Urothelial Carcinoma", "Solid Tumor", "Advanced Cancer" ], "interventions": [ { "name": "IPI-549 (eganelisib)", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Infinity Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2019-09-25", "completion_date": "2022-11-15", "has_results": false, "last_update_posted_date": "2022-11-25", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 7, "location_summary": "Fort Wayne, Indiana • Baltimore, Maryland • Detroit, Michigan + 4 more", "locations": [ { "city": "Fort Wayne", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Saint Cloud", "state": "Minnesota" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03980041" }, { "nct_id": "NCT05462561", "title": "Vascularized Composite Bladder Allograft Transplantation", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neurogenic Bladder", "Bladder Dysfunction", "Immunosuppression" ], "interventions": [ { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Robotic Vascularized Composite Bladder Allograft Transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 5, "start_date": "2023-05-01", "completion_date": "2028-10-03", "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05462561" }, { "nct_id": "NCT06973161", "title": "ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bladder Cancer", "Biliary Tract Cancer", "Cervical Cancer", "Endometrial Cancer", "Ovarian Cancer", "Pancreatic Cancer", "Colorectal Cancer", "Lung Cancer", "Other Tumors" ], "interventions": [], "intervention_types": [], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 140, "start_date": "2025-06-10", "completion_date": "2026-03-17", "has_results": false, "last_update_posted_date": "2026-04-08", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 2, "location_summary": "Spartanburg, South Carolina • Houston, Texas", "locations": [ { "city": "Spartanburg", "state": "South Carolina" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06973161" }, { "nct_id": "NCT06002269", "title": "A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bladder Cancer", "Cystectomy", "Chemotherapy" ], "interventions": [ { "name": "Dietary and Exercise Intervention", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2024-06-04", "completion_date": "2025-07-08", "has_results": false, "last_update_posted_date": "2025-07-20", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06002269" }, { "nct_id": "NCT00004856", "title": "Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Distal Urethral Cancer", "Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter", "Proximal Urethral Cancer", "Recurrent Bladder Cancer", "Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter", "Recurrent Urethral Cancer", "Stage IV Bladder Cancer", "Transitional Cell Carcinoma of the Bladder", "Urethral Cancer Associated With Invasive Bladder Cancer" ], "interventions": [ { "name": "trastuzumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2002-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-05-03", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004856" }, { "nct_id": "NCT01851395", "title": "Rapid Autopsy and Procurement of Cancer Tissue", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Thymus Tumors", "Adoptive Cellular Therapy", "Mesothelioma", "Genitourinary Cancers", "Lung Cancers" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 32, "start_date": "2013-12-30", "completion_date": "2025-10-14", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01851395" }, { "nct_id": "NCT00981656", "title": "Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "5-fluorouracil", "type": "DRUG" }, { "name": "Mitomycin", "type": "DRUG" }, { "name": "Three-Dimensional Conformal Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 37, "start_date": "2009-11", "completion_date": "2023-08-15", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-25T14:23:22.549Z", "location_count": 13, "location_summary": "Atlanta, Georgia • Baltimore, Maryland • Fall River, Massachusetts + 9 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Fall River", "state": "Massachusetts" }, { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT00981656" } ] }